The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)

Author:

Eccleston David S.1,Kim Joseph M.2ORCID,ten Berg Jurien M.3,Steg P. Gabriel4ORCID,Bhatt Deepak L.2,Hohnloser Stefan H.5,de Veer Anne,Nordaby Matias6,Miede Corinna7,Kimura Takeshi8,Lip Gregory Y. H.910ORCID,Oldgren Jonas11,Cannon Christopher P.2ORCID

Affiliation:

1. Department of Medicine University of Melbourne and GenesisCare Melbourne Australia

2. Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

3. Department of Cardiology St. Antonius Ziekenhuis Nieuwegein Netherlands

4. FACT, an F‐CRIN Network, DHU FIRE Université Paris Diderot, INSERM U_1148 and Hôpital Bichat Assistance Publique Paris France

5. Johann Wolfgang Goethe University Department of Cardiology, Division of Clinical Electrophysiology Frankfurt am Main Germany

6. Boehringer Ingelheim GmbH Ingelheim Germany

7. Mainanalytics GmbH Sulzbach (Taunus) Germany

8. Kyoto University Department of Cardiovascular Medicine Kyoto Japan

9. Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart & Chest Hospital Liverpool UK

10. Department of Clinical Medicine, Aalborg Thrombosis Research Unit Aalborg University Aalborg Denmark

11. Department of Medical Sciences and Uppsala Clinical Research Center Uppsala University Uppsala Sweden

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3